Advertisement

Topics

Actos

21:07 EDT 21st September 2017 | BioPortfolio

Actos, produced by Takeda Pharmaceuticals North America, Inc netted $2.5m in sales in 2009, the 9th highest in the world.

Actos is a type of thiazolidinediones, acting to increase sensitivity to Insulin. This sensitivity is lost in Type II Diabetes, the disease which Actos is prescribed for. Diabetes (Type II) is becoming increasingly common in the developed world, and may explain the high sales value of this drug. 

Source; Adapted from BioPortfolio.com and Actos.com

Add the Actos News Channel to your RSS reader;

Follow the Actos Twitter feed;

Quick Search
Advertisement
 

review and buy Actos market research data and corporate reports here